Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices (Protocol)
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices (Protocol). / Gluud, Lise Lotte; Morgan, Marsha Y.
I: Cochrane Database of Systematic Reviews, Bind 2017, Nr. 6, CD012694, 2017.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices (Protocol)
AU - Gluud, Lise Lotte
AU - Morgan, Marsha Y.
PY - 2017
Y1 - 2017
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of endoscopic therapy and beta-blockers used as a combination therapy versus monotherapy with either endoscopic therapy or beta-blockers for secondary prevention in people with cirrhosis and oesophageal varices.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of endoscopic therapy and beta-blockers used as a combination therapy versus monotherapy with either endoscopic therapy or beta-blockers for secondary prevention in people with cirrhosis and oesophageal varices.
U2 - 10.1002/14651858.CD012694
DO - 10.1002/14651858.CD012694
M3 - Review
AN - SCOPUS:85020753293
VL - 2017
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
SN - 1361-6137
IS - 6
M1 - CD012694
ER -
ID: 189321914